High Tower Advisors, LLC Fate Therapeutics Inc Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 10,600 shares of FATE stock, worth $24,274. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,600
Previous 11,204 5.39%
Holding current value
$24,274
Previous $36,000 2.78%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.12 - $5.57 $1,884 - $3,364
-604 Reduced 5.39%
10,600 $37,000
Q2 2024

Aug 13, 2024
BUY
$3.26 - $7.08 $339 - $736
104 Added 0.94%
11,204 $36,000
Q1 2024

May 06, 2024
BUY
$3.54 - $8.35 $708 - $1,670
200 Added 1.83%
11,100 $81,000
Q4 2023

Feb 12, 2024
SELL
$1.65 - $3.94 $8,367 - $19,979
-5,071 Reduced 31.75%
10,900 $40,000
Q3 2023

Nov 08, 2023
SELL
$2.02 - $5.04 $404 - $1,008
-200 Reduced 1.24%
15,971 $33,000
Q2 2023

Aug 14, 2023
SELL
$4.76 - $6.59 $2,308 - $3,196
-485 Reduced 2.91%
16,171 $76,000
Q1 2023

May 11, 2023
BUY
$4.24 - $11.12 $3,735 - $9,796
881 Added 5.58%
16,656 $94,000
Q4 2022

Feb 08, 2023
SELL
$9.86 - $23.83 $16,702 - $40,368
-1,694 Reduced 9.7%
15,775 $159,000
Q3 2022

Nov 09, 2022
BUY
$21.04 - $36.06 $147,679 - $253,105
7,019 Added 67.17%
17,469 $391,000
Q2 2022

Aug 10, 2022
SELL
$17.78 - $42.39 $140,657 - $335,347
-7,911 Reduced 43.09%
10,450 $261,000
Q1 2022

May 12, 2022
BUY
$29.67 - $60.28 $30,144 - $61,244
1,016 Added 5.86%
18,361 $714,000
Q4 2021

Feb 10, 2022
BUY
$47.84 - $64.34 $200,066 - $269,069
4,182 Added 31.77%
17,345 $1.02 Million
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $28,864 - $46,620
-487 Reduced 3.57%
13,163 $779,000
Q2 2021

Aug 06, 2021
BUY
$67.25 - $92.52 $477,340 - $656,706
7,098 Added 108.33%
13,650 $1.19 Million
Q1 2021

May 10, 2021
BUY
$72.16 - $117.4 $472,792 - $769,204
6,552 New
6,552 $540,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $222M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email